OTC Markets OTCQX - Delayed Quote USD
CSL Limited (CSLLY)
76.42
-0.02
(-0.03%)
At close: April 22 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | 3.36 | 3.73 |
| Low Estimate | 0 | 0 | 3.36 | 3.73 |
| High Estimate | 0 | 0 | 3.36 | 3.73 |
| Year Ago EPS | -- | -- | 3 | 3.36 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 17 | 17 |
| Avg. Estimate | -- | -- | 15.7B | 16.71B |
| Low Estimate | -- | -- | 15.04B | 16.2B |
| High Estimate | -- | -- | 16.09B | 17.22B |
| Year Ago Sales | -- | -- | 14.8B | 15.7B |
| Sales Growth (year/est) | -- | -- | 6.09% | 6.42% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 3.36 | 3.73 |
| 7 Days Ago | 0 | 0 | 3.36 | 3.72 |
| 30 Days Ago | 0 | 0 | 3.3 | 3.9 |
| 60 Days Ago | 0 | 0 | 3.32 | 3.94 |
| 90 Days Ago | 0 | 0 | 3.39 | 3.98 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CSLLY | -- | -- | 12.12% | 11.08% |
| S&P 500 | 7.01% | 4.85% | 8.55% | 14.15% |
Related Tickers
INRLF Valneva SE
2.8200
0.00%
GLPGF Galapagos NV
22.39
0.00%
IVBXF Innovent Biologics, Inc.
5.98
0.00%
TLPPF Telix Pharmaceuticals Limited
15.90
0.00%
BNTC Benitec Biopharma Inc.
13.79
-0.11%
APGE Apogee Therapeutics, Inc.
35.50
+8.07%
MIRM Mirum Pharmaceuticals, Inc.
39.43
+2.71%
ACLX Arcellx, Inc.
63.12
+3.59%
SPRO Spero Therapeutics, Inc.
0.7322
+0.99%
LIPO Lipella Pharmaceuticals Inc.
2.3950
+5.51%